Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors

Aug. 8, 2023—A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors.

Read more